ES2060708T3 - Sistema terapeutico de liberacion retardada para formulaciones farmaceuticas liquidas. - Google Patents

Sistema terapeutico de liberacion retardada para formulaciones farmaceuticas liquidas.

Info

Publication number
ES2060708T3
ES2060708T3 ES89116855T ES89116855T ES2060708T3 ES 2060708 T3 ES2060708 T3 ES 2060708T3 ES 89116855 T ES89116855 T ES 89116855T ES 89116855 T ES89116855 T ES 89116855T ES 2060708 T3 ES2060708 T3 ES 2060708T3
Authority
ES
Spain
Prior art keywords
therapeutic
pharmaceutical formulations
delayed release
release system
liquid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89116855T
Other languages
English (en)
Inventor
Giancarlo Santus
Roberto Golzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati SA
Original Assignee
Recordati SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati SA filed Critical Recordati SA
Application granted granted Critical
Publication of ES2060708T3 publication Critical patent/ES2060708T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Management Or Editing Of Information On Record Carriers (AREA)
  • Indexing, Searching, Synchronizing, And The Amount Of Synchronization Travel Of Record Carriers (AREA)

Abstract

EL OBJETO DEL PRESENTE INVENTO ES UN SISTEMA TERAPEUTICO DE EVACUACION CONTROLADA PARA COMPOSICIONES LIQUIDAS FARMACEUTICAS QUE CONSISTE EN: A) MICROGRANULOS QUE CONTIENEN PRINCIPIOS ACTIVOS EN PARTICULAR TEOFILINA, QUE TIENE DIMENSIONES PARA SER CONSERVADA FACILMENTE EN SUSPENSION EN UN MEDIO LIQUIDO, Y APTA PARA SER TRATADA DE ESTE MODO PARA MOSTRAR LAS CARACTERISTICAS PARTICULARMENTE INDICADAS PARA PELICULAS DE PROTECCION; B) UNA SERIE DE PELICULAS MULTILAMINADAS LAS CUALES PROTEGEN DICHOS MICROGRANULOS Y PERMITEN LA EVACUACION CONTROLADA A UN PREDETERMINADO TIEMPO DEL PRINCIPIO ACTIVO CONTENIDO EN LOS GRANULOS Y AL MISMO TIEMPO CONCEBIDA PARA MANTENER LAS CARACTERISTICAS DE EVACUACION POR LARGOS PERIODOS DE TIEMPO; C) UN VEHICULO PARA LA ADMINISTRACION DE LA DOSIS DE LIQUIDO RECONSTITUIBLE POR CONTENER UNA CANTIDAD ACEPTABLE INMEDIATAMENTE DEL PRINCIPIO ACTIVO. UN PROCESO PARA LA PREPARACION DE DICHO SISTEMA ES TAMBIEN DESCRITO
ES89116855T 1988-09-16 1989-09-12 Sistema terapeutico de liberacion retardada para formulaciones farmaceuticas liquidas. Expired - Lifetime ES2060708T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8821961A IT1226940B (it) 1988-09-16 1988-09-16 Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide

Publications (1)

Publication Number Publication Date
ES2060708T3 true ES2060708T3 (es) 1994-12-01

Family

ID=11189446

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89116855T Expired - Lifetime ES2060708T3 (es) 1988-09-16 1989-09-12 Sistema terapeutico de liberacion retardada para formulaciones farmaceuticas liquidas.

Country Status (14)

Country Link
EP (1) EP0359195B1 (es)
JP (1) JP2719835B2 (es)
KR (1) KR0133531B1 (es)
CN (1) CN1043508C (es)
AT (1) ATE98485T1 (es)
AU (1) AU616562B2 (es)
CA (1) CA1338569C (es)
DE (1) DE68911439T2 (es)
DK (1) DK456789A (es)
ES (1) ES2060708T3 (es)
FI (1) FI103014B1 (es)
IL (1) IL91611A0 (es)
IT (1) IT1226940B (es)
NO (1) NO178133C (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
EP0923312A1 (en) * 1996-04-29 1999-06-23 K.U. Leuven Research & Development Oral delivery form having a high absorption efficiency and method for making same
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
CA2261787C (en) * 1997-05-30 2006-11-14 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
JP2000128774A (ja) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
DE19856149C1 (de) * 1998-12-04 2000-06-15 Basf Ag Verfahren zur Herstellung von Agglomeraten mit Kern-Schale-Struktur
CA2395993A1 (en) * 1999-12-28 2001-07-05 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
EP1492511B3 (fr) 2002-04-09 2012-05-02 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
KR20090088913A (ko) * 2006-11-21 2009-08-20 맥네일-피피씨, 인코포레이티드 개질된 방출형 진통 현탁제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
WO1987007833A1 (en) * 1986-06-20 1987-12-30 Shacknai Jonah Oral sustained release medicament
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
EP0359195B1 (en) 1993-12-15
AU616562B2 (en) 1991-10-31
KR900004328A (ko) 1990-04-12
FI103014B (fi) 1999-04-15
JP2719835B2 (ja) 1998-02-25
NO893677D0 (no) 1989-09-14
DK456789D0 (da) 1989-09-15
NO178133C (no) 1996-01-31
EP0359195A2 (en) 1990-03-21
FI103014B1 (fi) 1999-04-15
CN1043508C (zh) 1999-06-02
FI894272L (fi) 1990-03-17
DE68911439D1 (de) 1994-01-27
NO893677L (no) 1990-03-19
ATE98485T1 (de) 1994-01-15
IT1226940B (it) 1991-02-22
IL91611A0 (en) 1990-04-29
DE68911439T2 (de) 1994-04-14
IT8821961A0 (it) 1988-09-16
CA1338569C (en) 1996-09-03
FI894272A0 (fi) 1989-09-11
CN1041104A (zh) 1990-04-11
JPH02121918A (ja) 1990-05-09
EP0359195A3 (en) 1991-04-24
KR0133531B1 (ko) 1998-04-23
NO178133B (no) 1995-10-23
AU4135789A (en) 1990-03-22
DK456789A (da) 1990-03-17

Similar Documents

Publication Publication Date Title
AR033688A1 (es) Composicion parenteral reconstituible
ES2060708T3 (es) Sistema terapeutico de liberacion retardada para formulaciones farmaceuticas liquidas.
KR950007859A (ko) 경구 투여용 라파마이신 제형
ES2035821T3 (es) Sistema de administracion enterica dirigida.
AR035533A1 (es) Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
BR9206631A (pt) Sistema de maior penetração na pele para melhor administração tópica de medicamentos
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
DE68907139D1 (de) Mikrokapsel mit verzoegerter freigabe fuer wasserloesliche arzneistoffe.
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
BR9206632A (pt) Sistema de penetração na pele melhorado para melhorada liberação tópica de drogas
ES2064564T3 (es) Sistema de liberacion pulsatil de dosis unitaria diaria de minociclina.
ES2094539T3 (es) Preparacion farmaceutica y procedimiento para su preparacion.
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
AR031072A1 (es) Composiciones anticonvulsivas y el uso de las mismas para la manufactura de un medicamento
ES2031805T1 (es) Derivados del t-4 soluble.
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
HUP9901890A2 (hu) Gyógyszer és eljárás szervezet gyógyszeres kezelésére
AR013967A1 (es) UNA FORMULACION MEDICAMENTOSA PARA LA ADMINISTRACION ORAL DE PELLET DE DIFUSION CONTROLADA QUE TIENE LIBERACION CONTROLADA DE UN COMPUESTO ACTIVO QUE ES SELECCIONADO DEL ACIDO 1-CICLOPROPIL-7- [(S,S)-2,8-DIAZABICICLO [4.3.0] NON-8-IL ]-6-FLuOR-1,4-DIHIDRO-8-METOXI-4-OXO-3-QUINOLON CARBOXILICO O SALE
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
ES2126114T3 (es) Composiciones liquidas estables de interferon gamma.
UY25950A1 (es) Procedimiento para preparar composiciones de tratamiento oral para la prevencion de la resorcion osea
JPH03169812A (ja) トリアセチンを含む活性持続性注射用処方剤
ES2187038T3 (es) Glicosidos modificados, composiciones que los comprenden y procedimientos para su utilizacion.
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 359195

Country of ref document: ES